SCHEMBL7722271

SCHEMBL7722271

CC(C)(C)OC(=O)NCC1C[C@@H](C(=O)Nc2ccc(Oc3ccccc3)cc2)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.47
NPC1 O15118 1/20 0.45
HDAC8 Q9BY41 2/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
S1PR1 P21453 3/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP3A4 P08684 2/20 0.43
POLB P06746 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
PABPC1 P11940 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
RECQL P46063 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CFTR P13569 1/20 0.41
DRD2 P14416 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7722273 1.00 NAMPT (0.47) NAMPTNPC1HDAC8MEN1KMT2A
SCHEMBL7731475 0.84 HDAC8 (0.44) NPC1HDAC8MEN1KMT2ACYP3A4
SCHEMBL7728020 0.83 MEN1 (0.62) NPC1HDAC8MEN1KMT2ACYP2C9
SCHEMBL7728024 0.83 MEN1 (0.62) NPC1HDAC8MEN1KMT2ACYP2C9
SCHEMBL7728781 0.83 MEN1 (0.62) NPC1HDAC8MEN1KMT2ACYP2C9
SCHEMBL7728565 0.82 MEN1 (0.51) NPC1HDAC8MEN1KMT2ACYP2C9
SCHEMBL7728568 0.82 MEN1 (0.51) NPC1HDAC8MEN1KMT2ACYP2C9
SCHEMBL7722275 0.81 HDAC8 (0.42) NPC1HDAC8MEN1KMT2AS1PR1
SCHEMBL7721946 0.81 HDAC8 (0.41) NPC1HDAC8MEN1KMT2ACYP3A4
SCHEMBL7727705 0.79 NPC1 (0.46) NPC1HDAC8MEN1KMT2AS1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed